https://doi.org/10.4081/monaldi.2021.1708
COVID-19: the difference between the nose and the lung
Published: March 5, 2021
Abstract Views: 1145
PDF: 565
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
To the Editor
An elegant study reported dysmorphic cells and syncytia in the deceased's lungs for COVID-19. The authors reasonably considered that most of these syncytia-forming cells were pneumocytes, as identified by specific biomarkers. However, cellular dysmorphism and syncytia are pathological features common in other respiratory infections caused by different viruses, including the human respiratory syncytial virus (HRSV) and Epstein-Barr virus (EBV), as correctly documented...
Bussani R, Schneider E, Zentilin L, et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology. EBioMedicine 2020;61:103104.
DOI: https://doi.org/10.1016/j.ebiom.2020.103104
Gagliardi TB, Ferreira Criado M, Proenca-Modena JL, et al. Syncytia induction by clinical isolates of human respiratory syncytial virus A. Intervirology 2017;60:56-60.
DOI: https://doi.org/10.1159/000480014
Gelardi M, Tomaiuolo M, Cassano M, et al. Epstein-Barr virus induced cellular changes in nasal mucosa. Virology J 2006;3:6.
DOI: https://doi.org/10.1186/1743-422X-3-6
Gelardi M, Ciprandi G. Ciliocytophthoria of nasal epithelial cells after viral infection: a sign of suffering cell. Acta Biomed 2019;90:7-9.
Gelardi M, Notargiacomo M, Trecca EMC, Cassano M. SARS-CoV-2: Naso-bronchial cytological correlations. Am J Otolaryngol 2020;41:102549.
DOI: https://doi.org/10.1016/j.amjoto.2020.102549
How to Cite
Gelardi, Matteo, Mario Notargiacomo, Eleonora Maria Consiglia Trecca, Michele Cassano, and Giorgio Ciprandi. 2021. “COVID-19: The Difference Between the Nose and the Lung”. Monaldi Archives for Chest Disease 91 (2). https://doi.org/10.4081/monaldi.2021.1708.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- E. Yilmaz, A. Akkoclu, A. Gulsen, E. Osma, Arteriovenous malformations of the lung: diagnosis by thin-section HRCT and Cine-MRI , Monaldi Archives for Chest Disease: Vol. 61 No. 3 (2004): Pulmonary series
- K. Psathakis, V. Skouras, F. Chatzivassiloglou, K. Tsintiris, Osteophytes may be a rare cause of recurrent pleural effusions , Monaldi Archives for Chest Disease: Vol. 79 No. 2 (2013): Pulmonary series
- Fulvio Cacciapuoti, Erica Vetrano, Federico Cacciapuoti, Left atrial invasion of a lung cancer: a case report , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Tochukwu Adizie, Lauren Dolan, Aqusa Zahid, Ahmed Fahim, Assessing disease activity in scleroderma-related interstitial lung disease: a review and practical guide to management , Monaldi Archives for Chest Disease: Early Access
- Alberto Papi, Maria Sandra Magnoni, Carmelo Caio Muzzio, Gianmarco Benso, Andrea Rizzi, Phenomenology of COPD: interpreting phenotypes with the ECLIPSE study , Monaldi Archives for Chest Disease: Vol. 83 No. 1-2 (2016): Pulmonary series
- Joo Ock Na, Dong Soon Kim, Seong Ho Yoon, Yang Jin Jegal, Woo Sung Kim, Eung Suk Kim, Myung Wha Kim, A simple and easy home-based pulmonary rehabilitation programme for patients with Chronic Lung Diseases , Monaldi Archives for Chest Disease: Vol. 63 No. 1 (2005): Pulmonary series
- Davorka Muršić, Tajana Jalušić Glunčić, Jelena Ostojić, Sanda Škrinjarić Cincar, Ljiljana Bulat Kardum, Martina Dokoza, Nataša Karamarković Lazarušić, Erim Bešić, Miroslav Samaržija, Andrea Vukić Dugac, Differences in nutritional status of patients with chronic obstructive pulmonary disease between Mediterranean and non-Mediterranean regions in Croatia , Monaldi Archives for Chest Disease: Early Access
- R.W. Dal Negro, M. Guerriero, Cultural and linguistic testing of the Handling Questionnaire: a specific instrument for assessing the patient’s acceptability of dry powder inhalers , Monaldi Archives for Chest Disease: Vol. 69 No. 4 (2008): Pulmonary series
- I. Blanco, H. Canto, J. Flóres, C. Camblor, V. Cárcaba, F.J. de Serres, S. Janciauskiene, E.F. Bustillo, Long-term augmentation therapy with Alpha-1 Antitrypsin in an MZ-AAT severe persistent asthma , Monaldi Archives for Chest Disease: Vol. 69 No. 4 (2008): Pulmonary series
- G.C. Maglaras, S. Katsenos, J. Kakadelis, C. Katsanos, Z. Metafratzi, D.G. Stefanou, M.P. Vassiliou, S.H. Constantopoulos, Primary angiosarcoma of the lung and pleura , Monaldi Archives for Chest Disease: Vol. 61 No. 4 (2004): Pulmonary series
<< < 14 15 16 17 18 19 20 21 22 23 > >>
You may also start an advanced similarity search for this article.
